Advertisement

Pancreatic Diseases

  • Michael R. Spieker
  • Susan C. Cullom
Chapter

Abstract

Diseases of the pancreas cause significant morbidity and mortality in Western countries. In addition to caring for the acutely ill patient, family physicians can more successfully treat patients with pancreatic diseases by effective intervention in the patient’s life style and family issues. This intervention may disrupt a pattern of chronic alcohol abuse and provide supportive care for the family of the patient.

Keywords

Pancreatic Cancer Acute Pancreatitis Chronic Pancreatitis Acute Necrotizing Pancreatitis Pancreatic Abscess 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ranson JHC, Rifkind KM, Roese DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974;139: 69–81.PubMedGoogle Scholar
  2. 2.
    Stanten R, Frey CF. Comprehensive management of acute necrotizing pancreatitis and pancreatic abscess. Arch Surg 1990;125:1269–75.PubMedCrossRefGoogle Scholar
  3. 3.
    Venu RP, Geemen JE, Howgan W, Stone J, Johnson GK, Soergel K. Idiopathic recurrent pancreatitis: an approach to diagnosis and treatment. Dig Dis Sci 1989;34:56–60.CrossRefGoogle Scholar
  4. 4.
    Van Sonnenberg E, Stabile BE, Varney RR, Christensen RR. Percutaneous drainage of infected and non-infected pseudocysts. Radiology 1989;170:757–62.Google Scholar
  5. 5.
    Bradley EL. A clinically based classification system for acute pancreatitis: summary of the international symposium on acute pancreatitis. Arch Surg 1993;128:586–90.PubMedCrossRefGoogle Scholar
  6. 6.
    Blarney SL, Imrie CW, O’Neill J, Gilmour WH, Carter DC. Prognostic factors in acute pancreatitis. Gut 1984;25:1340–6.CrossRefGoogle Scholar
  7. 7.
    Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990;77:1260–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Steinberg WM, Tenner S. Acute pancreatitis. N Engl J Med 1994;330:1198–1210.PubMedCrossRefGoogle Scholar
  9. 9.
    Pederzoli P, Bassi C, Vesentini S, Campedelli A. A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 1993;176:480–93.PubMedGoogle Scholar
  10. 10.
    Neoptolemos JP, Carr-Locke DL, London NJ, Bailey IA, James D, Fossard DP. Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment or acute pancreatitis due to gallstones. Lancet 1988;2:979–83.PubMedCrossRefGoogle Scholar
  11. 11.
    Singer MV, Gyr KE, Sarles H. Revised classification of pancreatitis: report of the Second International Symposium on the Classification of Pancreatitis in Marseilles, France, March 28–30,1984. Gastroenterology 1985;89:683–5.PubMedGoogle Scholar
  12. 12.
    Axon ATR, Classen M, Cotton PB, Cremer M, Freeny PC, Lees WR. Pancreatography in chronic pancreatitis: international definitions. Gut 1984;25:1107–12.PubMedCrossRefGoogle Scholar
  13. 13.
    Lankisch PG, Lohr-Happe A, Otto J, Creutzfeldt W. Natural course in chronic pancreatitis: pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion 1993;54:148–55.PubMedCrossRefGoogle Scholar
  14. 14.
    Murr M, Sarr M. Pancreatic cancer. CA J Clin Cancer 1994;44: 304–18.CrossRefGoogle Scholar
  15. 15.
    Urrutia R, DiMagno E. Genetic markers: the key to early diagnosis and improved survival in pancreatic cancer? Gastroenterology 1996;110:306–10.PubMedCrossRefGoogle Scholar
  16. 16.
    Tada M, Ohashi M. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 1996;110:227–31.PubMedCrossRefGoogle Scholar
  17. 17.
    Liu C, Rongione A, Garvey L. Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth. Am J Surg 1996;171:192–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Carmichael J, Fink U, Russell RC, et al. Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer 1996;73:101–5.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Michael R. Spieker
  • Susan C. Cullom

There are no affiliations available

Personalised recommendations

Cite chapter

Buy options